(NASDAQ: IMNN) (the “Company”), a clinical-stage company in late-stage development with its DNA-mediated immunotherapy, today announced that the Compensation Committee of the Company’s Board of ...
FibroBiologics, Inc., (Nasdaq: FBLG) ("FibroBiologics”) and Charles River Laboratories ("Charles River”), a leading global drug discovery, development, testing, and manufacturing solutions provider ...
Under the terms of the merger agreement, Kayak Mergeco, Inc., Kintara's wholly-owned subsidiary, will merge with and into the private-company TuHURA, with TuHURA surviving the merger and becoming the ...
Global Plasmid Purification Market was valued at approximately USD 1.78 billion in 2023, exhibiting a robust CAGR of 11.69% throughout the forecast period from 2024 to 2032. Read the Market Summary ...